Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label chronic HCV patients who failed previous therapy with DAAs. Show all posts
Showing posts with label chronic HCV patients who failed previous therapy with DAAs. Show all posts
Monday, July 11, 2016

AbbVie's ABT-493 and ABT-530 achieve high SVR rates in GT1 chronic HCV patients who failed previous therapy with DAAs

›
ABT-493 ABT-530 ribavirin (RBV AbbVie, a global biopharmaceutical company, today announced that 91 percent (n=20/22) o...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.